Gabriel Reina
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 9
- SARS-CoV-2 and COVID-19 Research 7
- HIV/AIDS drug development and treatment 7
- Modeling and Simulation top 5%
- Hepatology top 5%
- Epidemiology top 5%
- Influenza Virus Research Studies 14
- Respiratory viral infections research 13
- Hepatitis B Virus Studies 7
- Health top 5%
-
- HIV Research and Treatment 7
-
- T-cell and Retrovirus Studies 5
- Co-authors
- Jesús CastillaIván Martínez‐BazMarcela GuevaraVíctor Martínez-ArtolaCarmen EzpeletaManuel Garcìa CenozSilvia CarlosFrancisco Pozo
- Partner nations
- SpainDemocratic Republic of the CongoUnited States
In The Last Decade
Gabriel Reina
65 papers receiving 906 citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 397
- Modeling and Simulation 94
- Hepatology 144
- Epidemiology 508
- Health 109
Countries citing papers authored by Gabriel Reina
This map shows the geographic impact of Gabriel Reina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Reina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Reina more than expected).
Fields of papers citing papers by Gabriel Reina
This network shows the impact of papers produced by Gabriel Reina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Reina. The network helps show where Gabriel Reina may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gabriel Reina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 16 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 81 | |
| 12 | 2022 | 13 | |
| 13 | 2022 | 15 | |
| 14 | 2022 | 2 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 17 | |
| 17 | 2021 | 13 | |
| 18 | 2016 | 5 | |
| 19 | 2014 | 18 | |
| 20 | An ELISA method in the diagnosis of typhoid fever. | 1990 | 2 |
About Gabriel Reina
Gabriel Reina is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 71 papers that have together received 933 indexed citations. Recurring topics across this work include Influenza Virus Research Studies (14 papers), Respiratory viral infections research (13 papers), HIV/AIDS Research and Interventions (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Hepatitis B Virus Studies (7 papers), HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (7 papers) and T-cell and Retrovirus Studies (5 papers). The work is most often cited by research in Infectious Diseases (397 citations), Modeling and Simulation (94 citations) and Hepatology (144 citations). Gabriel Reina has collaborated with scholars based in Spain, Democratic Republic of the Congo and United States. Frequent co-authors include Jesús Castilla, Iván Martínez‐Baz, Marcela Guevara, Víctor Martínez-Artola, Carmen Ezpeleta, Manuel Garcìa Cenoz, Silvia Carlos, Francisco Pozo, Maite Arriazu and Aurelio Barricarte. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.